Hangzhou Tigermed Consulting Co Ltd

• Country

  China

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Life Sciences Tools & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  6271.2

• Ticker

  HNGZY.PK

• ISIN

  US41044T1088

• IPO date

  2012-08-17

• Availability on Russian exchanges

  No

• Reporting for

• Date fact. publication of reports

Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The Company operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The Company conducts its businesses in the domestic and overseas markets.